COMP <GO>
VANI vs NRXS // ALTMAN Z-SCORE & DEBT/EQUITY
Vivani Medical Inc. (NASDAQ) VS. Neuraxis Inc. (NYSE) • 15-METRIC TALLY: VANI 1
— NRXS 3
■ METRIC PARITY
LAST: $1.14 (0.00%) • MKT CAP: $102.8M
balance-sheet
—
LAST: $7.55 (-0.26%) • MKT CAP: $94.8M
balance-sheet
1.88
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VANI VS. NRXS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VANI | NRXS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 84.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.79% | -6.82% | -17.97 | NRXS | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 32.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 1.88 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | NRXS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.0 | 54.9 | -9.90 | NRXS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $102.8M | $94.8M | $8.0M | VANI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VANI REV | NRXS REV | VANI GROSS % | NRXS GROSS % | VANI FCF | NRXS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $3.6M | — | 84.2% | -$25.5M | -$6.5M |
| FY 2024 | $0 | $2.7M | — | 86.5% | -$21.3M | -$6.1M |
| FY 2023 | $0 | $2.5M | — | — | -$23.7M | -$6.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VANI // BETA —
NRXS // BETA —